Thymidine phosphorylase triggers the phosphorylation of pyrimidine base to thymine and 2-deoxyribose 1-phosphate which undergoes dephosphorylation to 2-deoxyribose. It plays a role in tumor angiogenesis which is referred to the development of blood vessels during tumor growth and therefore is an attractive drug target. Keeping in view the greater importance of its inhibition, here in this study we have synthesized piperazine analogs (1-18) and evaluated for thymidine phosphorylase inhibitory activity. All analogs showed potent inhibitory potential with IC values ranging between 0.2 ± 0.01 and 42.20 ± 0.70 µM when compared with standard 7-Deazaxanthine (IC value of 38.68 ± 1.12 µM). Structure activity relationship has been also established for all newly synthesized compounds. Molecular docking studies revealed that these compounds established stronger hydrogen bonding networks with active site residues of enzyme.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bioorg.2018.03.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The prediction power of thymidine phosphorylase and IL-6 in the relapse of breast cancer.
Pol Merkur Lekarski
March 2025
FACULTY OF NURSING, UNIVERSITY OF KUFA, KUFA, IRAQ.
Objective: Aim: To investigate the role of thymidine phosphate and IL-6 in the pathogenesis and survival rate in women with breast cancer..
Patients And Methods: Materials and Methods: Sixty women diagnosed with breast cancer (with age ranging between 25-65 years) were included in the current study.
Computational framework for minimizing off-target toxicity in capecitabine treatment using natural compounds.
Mol Divers
February 2025
REACT - Computational Toxicology Group, CSIR- Indian Institute of Toxicology Research, Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, 226001, India.
Antineoplastic drugs are becoming prevalent due to increasing cancer casualties around the globe. However, the adverse effects of these drugs are evident due to limited insight into the underlying mechanisms that result in non-specific binding and consequent off-target toxicity. The study investigates the side effects of an antineoplastic drug, Capecitabine, a prodrug converted into fluorouracil by Thymidine Phosphorylase (TP) and degrades the RNA of cancerous cells.
View Article and Find Full Text PDFBenzothiazole Derived Ether Hybrids as Potent Anti-Thymidine Phosphorylase Agents: Synthesis, In Vitro, and Computational Investigations.
Chem Biodivers
February 2025
Department of Chemistry, University of Malakand, Dir Lower, Khyber Pakhtunkhwa, Pakistan.
This work is based on the synthesis of new ether derivatives bearing benzothiazole (BTA) scaffold through multistep reaction process. Initially, BTA was prepared by refluxing 4-hydroxybenzaldehyde with aminothiophenol having sodium metabisulfite in dimethylformamide (DMF); subsequently, the product was further refluxed with different substituted benzyl and alkyl bromides in acetone to get ether hybrids of BTA in good yields. Structurally, these compounds were confirmed by means of H, C-NMR, and mass spectrometry and evaluated for in vitro thymidine phosphorylase (TP) inhibitory activity.
View Article and Find Full Text PDFInsight into thymidine phosphorylase and molecular docking studies: identification of hybrid thiazole bearing Schiff base derivatives.
Z Naturforsch C J Biosci
February 2025
Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
In pursuit of effective thymidine phosphorylase inhibitors, a series of hybrid analogs of thiazole-hydrazone derivatives (1-15) were synthesized and evaluated for their enzyme inhibitory potential using 7-deazaxanthine as a positive control. The goal was to determine these derivatives' effectiveness in suppressing thymidine phosphorylase activity, a target relevant to antitumor strategies due to the enzyme's role in angiogenesis and tumor growth. Biological evaluations indicated that all synthesized analogs displayed significant to moderate inhibitory activity, with IC values between 3.
View Article and Find Full Text PDFBeyond chemotherapy: Exploring 5-FU resistance and stemness in colorectal cancer.
Eur J Pharmacol
March 2025
School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, 751024, Odisha, India. Electronic address:
Article Synopsis
- Colorectal cancer (CRC) presents ongoing global health challenges, particularly in overcoming treatment resistance in cancer stem cells (CSCs) and the limitations of 5-fluorouracil (5-FU) therapy.
- Combination therapies and targeted treatments, such as FOLFOXIRI and various monoclonal antibodies, can boost the effectiveness of 5-FU, especially in specific tumor types, but come with considerable toxicity.
- Advances in personalized medicine, immunotherapy, and nanomedicine are vital for improving treatment outcomes by addressing the complexities of CRC and enhancing drug delivery while reducing resistance to conventional therapies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!